:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/22010796/a43a42112d445f61e50b38ed99ac15e2_wm.png)
What is the evidence for the management of urethral amyloidosis? A systematic review of the literature.
Summary: Urethral amyloidosis is a rare condition where abnormal proteins build up in the urinary tract, causing blockages similar to scar tissue. Traditionally, surgeons have treated this by simply cutting the blockage (urethrotomy) or stretching it. However, a new review of 49 cases suggests these "quick fix" methods often fail, leading to the blockage returning. The study finds that a more extensive reconstruction surgery, called urethroplasty, provides much better long-term results and should likely be the preferred treatment to prevent recurrence.
Tags
Recurrence
Disease Progression
Disease
Amyloidosis